(Total Views: 829)
Posted On: 12/12/2020 8:09:53 PM
Post# of 154064
CD12. Our tipping point.
We are weeks away from completion of our CD12 trial. Currently our fastest path to revenue. From all indications we are expecting to see a meaningful decrease in mortality. We don't know how much.
Provided the decrease is meaningful, a whole host of opportunities will open themselves up. All of our challenges will ease, and all of our frustrations will dissapate.
With EUA comes revenue and access to capital. But more importantly we get to start saving lives and reducing the fear that is gripping the planet.
We will have the opportunity to change this pandemic, and in return we will have the attention of those we need to have.
Fast forward to the point in time where the vaccines and Leronlimab and others have nuetered COVID..... We will have revenue, assets and access. Our safety profile will become WELL documented.
This is what we are really after. Not a one time dividend. For, at that point in time we will be able to run all of our trials concurrently. We will have more and more talent coming on board.
All, IMO. I cannot wait.
We are weeks away from completion of our CD12 trial. Currently our fastest path to revenue. From all indications we are expecting to see a meaningful decrease in mortality. We don't know how much.
Provided the decrease is meaningful, a whole host of opportunities will open themselves up. All of our challenges will ease, and all of our frustrations will dissapate.
With EUA comes revenue and access to capital. But more importantly we get to start saving lives and reducing the fear that is gripping the planet.
We will have the opportunity to change this pandemic, and in return we will have the attention of those we need to have.
Fast forward to the point in time where the vaccines and Leronlimab and others have nuetered COVID..... We will have revenue, assets and access. Our safety profile will become WELL documented.
This is what we are really after. Not a one time dividend. For, at that point in time we will be able to run all of our trials concurrently. We will have more and more talent coming on board.
All, IMO. I cannot wait.
(15)
(0)
